Invacare (NYSE:IVC) Lifted to “Hold” at ValuEngine

ValuEngine upgraded shares of Invacare (NYSE:IVC) from a sell rating to a hold rating in a research note published on Thursday, ValuEngine reports.

Other equities research analysts also recently issued reports about the company. Zacks Investment Research downgraded Invacare from a hold rating to a sell rating in a report on Thursday. Needham & Company LLC reiterated a buy rating and issued a $15.00 price target on shares of Invacare in a report on Tuesday, April 9th.

IVC stock traded down $0.02 during midday trading on Thursday, hitting $4.88. 435,879 shares of the company’s stock were exchanged, compared to its average volume of 313,749. The company has a quick ratio of 1.29, a current ratio of 1.97 and a debt-to-equity ratio of 0.78. Invacare has a 12-month low of $3.05 and a 12-month high of $18.25. The business has a 50 day moving average of $4.96.

Invacare (NYSE:IVC) last issued its quarterly earnings results on Monday, May 6th. The health services provider reported ($0.32) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.33) by $0.01. Invacare had a negative return on equity of 11.69% and a negative net margin of 4.56%. The business had revenue of $223.40 million during the quarter, compared to the consensus estimate of $229.93 million. During the same period in the previous year, the business earned ($0.35) EPS. The business’s quarterly revenue was down 5.8% on a year-over-year basis. As a group, sell-side analysts anticipate that Invacare will post -1.03 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Monday, July 22nd. Investors of record on Friday, July 5th were given a dividend of $0.0125 per share. The ex-dividend date of this dividend was Wednesday, July 3rd. This represents a $0.05 dividend on an annualized basis and a yield of 1.02%. Invacare’s dividend payout ratio is currently -3.79%.

A number of large investors have recently added to or reduced their stakes in IVC. Keeley Teton Advisors LLC boosted its position in Invacare by 103.7% during the 1st quarter. Keeley Teton Advisors LLC now owns 1,135,458 shares of the health services provider’s stock valued at $9,504,000 after purchasing an additional 578,003 shares during the period. Marshall Wace LLP boosted its position in Invacare by 141.0% during the 1st quarter. Marshall Wace LLP now owns 973,474 shares of the health services provider’s stock valued at $8,149,000 after purchasing an additional 569,509 shares during the period. Acadian Asset Management LLC acquired a new position in Invacare during the 1st quarter valued at approximately $1,321,000. Two Sigma Advisers LP acquired a new position in Invacare during the 4th quarter worth $327,000. Finally, Elk Creek Partners LLC boosted its position in Invacare by 2.4% during the 1st quarter. Elk Creek Partners LLC now owns 3,177,507 shares of the health services provider’s stock worth $26,596,000 after acquiring an additional 73,599 shares during the period.

About Invacare

Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through Europe, North America/Home Medical Equipment, Institutional Products Group, and the Asia/Pacific segments.

Read More: Moving Average – How it Helps Investors in Stock Selection

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.